NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design ...

QuantHealth helps pharma implement artificial intelligence for drug development using clinical trial simulation. Orr Inbar, its cofounder and CEO, discusses that — and the long-term effects of AI on ...

The "In Silico Clinical Trials Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market is undergoing rapid transformation, ...

QuantHealth's AI-powered clinical simulator predicts how an individual in a clinical trial will respond to treatment. The aim is to assist pharmaceutical companies in improving their clinical trial ...

Value added for clients: The use of AVL FIRE™ M and XPS delivers remarkable cost savings by reducing the need for extensive physical trials in R&D, using high fidelity models to predict outcomes. The ...

Simulations Plus, Inc. (NASDAQ:SLP) is one of the best healthcare AI stocks to buy now. On December 9, Simulations Plus, Inc. (NASDAQ:SLP) issued a press release highlighting how its technologies ...

AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...

During the Covid-19 pandemic, digital health technologies transformed the way that many of us received health care, supercharging the uptake of digital tools such as telehealth platforms, mobile ...